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mice generated 1.2 Ϯ 2.2% and 3.9 Ϯ 1.8% tone at 60 and 90 mmHg. The reason underlying the total loss of myogenic tone in the ASIC2 ϩ/Ϫ is not clear, although the loss of mechanosensitive ␤-and ␥-ENaC proteins may be a contributing factor. These results demonstrate that normal ASIC2 expression is required for normal pressureinduced constriction in the MCA. Furthermore, ASIC2 may be involved in establishing the basal level of myogenic tone. mechanotransduction; myogenic constriction; degenerin; acid-sensing ion channel IN CERTAIN blood vessels, a mechanically mediated response, termed pressure-induced constriction (also referred to as myogenic constriction), contributes to vascular resistance. In this response, increases in intraluminal pressure initially cause vessel stretch, which is thought to activate a mechanosensor in the vascular smooth muscle cell (VSMC). The activation of the mechanosensor initiates a signaling cascade, leading to VSMC contraction and vasoconstriction. Although mechanisms of vasoconstriction are well established, the identity of the VSMC sensor is unclear. Previous studies from our laboratory have focused on the role of the epithelial Na ϩ channel (ENaC) proteins.
ENaC proteins are members of a larger family of proteins called the degenerin (DEG)/ENaC/acid-sensing ion channel (ASIC) family. A large body of evidence links proteins to mechanotransduction. Certain DEG/ENaC/ASIC proteins are expressed in mechanosensitive tissue in a diverse range of species (nematode, drosophila, and vertebrate), and the disruption of expression alters normal mechanosensory responses. Two groups of DEG/ENaC/ASIC proteins have been identified in mammals: ENaC and ASIC. Our laboratory has previously demonstrated a role for ␤-and ␥-ENaC proteins in pressureinduced constrictor responses in renal and cerebral vessels (8, 15, 16) . However, the role of the closely related ASIC proteins has never been addressed.
ASIC proteins are excellent candidates to form a mechanosensory channel in VSMCs. A number of ASIC channels have been identified: ASIC1 [also known as brain Na ϩ channel (BNaC or BNC)2], ASIC2 [BNC1 or BNaC1, also known as mammalian DEG (MDEG)], ASIC3 (dorsal root ASIC), ASIC4 (spinal cord ASIC), and brain liver intestine Na ϩ channel (17) . ASIC proteins can interact to form homo-and heteromeric cation channels. ASIC proteins have been implicated in processes, including acid sensation, learning and memory, and mechanosensation (17, 20 -22, 24, 30, 31) . Several, but not all, studies support a role for ASIC2 in specific populations of visceral and peripheral mechanosensitive sensory neurons (22, 23) . However, not all reports are consistent (6, 26) .
A previous study by our laboratory demonstrated ASIC2 expression in cultured VSMCs; however, the importance of ASIC2 in pressure-induced constriction is unknown. Therefore, the goal of this study was to determine whether the DEG/ENaC protein, ASIC2, is required for pressure-induced vasoconstriction in cerebral vessels. To address this goal, we evaluated ASIC2 expression and agonist-and pressure-induced constriction using the ASIC2 mouse model (23) . Our results demonstrate that normal ASIC2 expression is required for normal pressure-induced constrictor responses in the mouse middle cerebral artery.
Michael J. Welsh and Margaret P. Price (University of Iowa). The generation of the knockout model, created by an insertion of a neomycin resistance cassette into a region coding for the second membrane-spanning domain, has been described previously (23) . The knockout model demonstrates no differences in appearance, growth, size, temperature, fertility, or life span and showed no obvious behavioral abnormalities. The current study utilized all male mice 6 -9 wk of age (mean, ϩ/ϩ, 6.7; ϩ/Ϫ, 8.2; and Ϫ/Ϫ, 8.2 wk) and one female ϩ/Ϫ littermate (8.1 wk).
The genotypic analysis of offspring from heterozygous mating pairs was screened by polymerase chain reaction (PCR). Tail DNA was isolated using direct PCR (Tail; Viagen Biotech, Los Angeles, CA), and PCR reactions were performed with AccuPrime Supermix (Invitrogen, Carlsbad, CA). Oligonucleotide sequences for the wildtype (WT) allele were 5Ј-AGTCCTGCACGGTGGGAGCTTCTA-3Ј and 5Ј-GAAGAGGAAGGGAGCCATGATGAG-3Ј. Oligonucleotide sequences for the knockout allele were 5Ј-ATGGTTTCGGAGTG-GTTTGGCATTGTG-3Ј and 5Ј-TGGATGTGGAATGTGTGCGA-3Ј. DNA specific to WT and knockout alleles was amplified using a Stratagene Robocycler under the following conditions. Samples were held at 94°C for 2 min, then cycled at 94°C for 30 s, 55°C for 30 s, and 68°C for 40 s, for 35 cycles, and then held at 68°C for 5 min. PCR products were separated on agarose gels and visualized using ethidium bromide. A sample genotypic analysis is shown in Fig. 1 . WT littermates of ASIC2 knockout mice were used as controls in all experiments.
Antibodies. For immunolabeling studies, antibodies specific to the ASIC2a (MDEG1) and ASIC2b (MDEG2) splice variants were obtained from commercial sources (Alpha Diagnostic, San Antonio, TX). The ASIC2a and ASIC2b antibodies are directed to the NH 2-terminal portion of the extracellular loop of the ASIC2a and ASIC2b splice variants. Additionally, an antibody that recognizes both splice variants was also developed. This antibody, named ASIC2a/b, was directed against the peptide sequence containing the COOH-terminal sequence [(498 -511) CVPLQTALGTLEEIA] common to the two known ASIC2 splice variants (ASIC2a and ASIC2b). The peptide was conjugated to keyhole limpet hemocyanin-maleimide and raised in rabbits (Affinity Bioreagents, Golden, CO). The antibodies were affinity purified against the original antigen. The antibody specificity was tested by Western blot analysis in the cerebral cortex (Fig. 2) and immunolabeling in VSMCs in ASIC2 WT and knockout mice. For Western blot analysis and certain immunolabeling studies, a goat anti-ASIC2 antibody (Santa Cruz Biotechnology, Santa Cruz, CA), directed to the extreme NH 2 terminus of ASIC2a, was also used. Antibodies to the COOH-terminal region of ␤-and ␥-ENaC, generated in rabbits, were also used (8, 15, 16) . As an internal control, we used mouse anti-smooth muscle ␣-actin (1:100; Sigma Chemicals, St. Louis, MO) and mouse anti-␤-actin (1:2,000; Abcam, Cambridge, MA) for immunostaining and immunoblotting studies, respectively.
Western blot analysis. The cerebral cortex was harvested from ASIC2 ϩ/ϩ , ϩ/Ϫ , and Ϫ/Ϫ mice and homogenized in 50 mM Tris ⅐ HCl, 150 mM NaCl, 1% Triton X-100, 2ϫ halt protease inhibitor cocktail (Pierce), and 1ϫ EDTA. The samples were vortexed, sonicated, and incubated at room temperature for 30 min. The samples were centrifuged at 16,000 g for 10 min to separate Triton X-100-soluble (cytosolic) and -insoluble (membrane associated) fractions. Proteins were separated using standard gel electrophoresis on 7.5% or 15% Tris ⅐ HCl gels (Bio-Rad, Hercules, CA). The proteins were transferred to nitrocellulose. After being rinsed in PBS, membranes were blocked in Odyssey blocking buffer (Li-Cor Biosciences) and then incubated overnight with our rabbit anti-ASIC2a/b (1:1,000) or goat anti- ϩ/ϩ mice (arrowhead). The intensity of the corresponding band was less intense in the ASIC2 ϩ/Ϫ and absent in the ASIC2 Ϫ/Ϫ cortex lysates. ␤-actin was used as a loading control. A nonspecific band was also detected in the Tx-I fraction near 75 kDa. ASIC2a (1:500) and mouse anti-␤-actin (1:1,000) with 0.1% Tween 20. The membranes were rinsed in PBS plus 0.1% Tween 20 and then incubated with secondary antibodies (1:2,000, donkey anti-rabbit IR700 or donkey anti-goat IR700 and donkey anti-mouse IR800; 1 h). The membranes were rinsed in PBS and then examined using the Odyssey infrared imaging system.
Enzymatic dissociation of VSMCs. To dissociate VSMCs, mice were first anesthetized with isoflurane and transcardially flushed with cold Hanks' balanced salt solution (HBSS). The brain was removed, and cerebral vessels were dissected and placed in ice-cold HBSS. VSMCs were dissociated by incubating enzymatic digestion solution I (26 U/ml papain and 1 mg/ml dithioerythritol in HBSS) for 15 min at 37°C with occasional agitation. Vessels were then incubated in solution II (2 U/ml collagenase, 1 mg/ml soybean trypsin inhibitor, and 75 U/ml elastase in HBSS) for 12 min at 37°C. After digestion, vessel segments were centrifuged and rinsed with HBSS. VSMCs were released by gently triturating the tissue with a fire-polished Pasteur pipette and passing dissociated VSMCs through a 70-m filter.
Immunolocalization in freshly dispersed VSMCs. To quantify ASIC2 expression and determine localization, freshly dissociated VSMCs were labeled using a technique previously published by our laboratory (7, 9, 10) . For this approach, dissociated VSMCs are fixed in 4% paraformaldehyde for 10 min and then air-dried to charged glass slides at 37°C. Unless noted otherwise, all incubations were for 1 h at room temperature. To immunolabel the VSMCs, the prepared cells were rinsed in PBS and blocked in 5% normal donkey serum (NDS). The samples were then incubated with primary antibodies [rabbit anti-ASIC2a, anti-ASIC2b, anti-ASIC2a/b, anti-␤-ENaC, or anti-␥-ENaC (1:100) and mouse anti-␣-smooth muscle actin (1:100)] in 5% NDS overnight at 4°C and then rinsed in PBS. The samples were incubated with Cy3-conjugated donkey anti-rabbit (1:100; Jackson Immunologicals) and Cy5-conjugated donkey anti-mouse (1:100) for 1 h in 5% NDS. After a final rinse in PBS, the samples were covered with Gel Mount mounting media and coverslipped. Antibody localization was visualized using confocal microscopy (Leica TCS SP2). Importantly, all samples were collected, immunolabeled, and imaged side by side under identical conditions. ASIC2 labeling was normalized to smooth muscle ␣-actin, an internal control. All images were prepared in Photoshop 6.0 (Adobe systems).
To determine colocalization of ASIC2 and ENaC, we used confocal microscopy. Dissociated VSMCs from a ASIC2 ϩ/ϩ mouse were incubated with rabbit anti-ASIC2, rabbit anti-␤-ENaC, or sheep anti-␥-ENaC and mouse anti-smooth muscle ␣-actin (1:100) in 5% NDS overnight at 4°C and then rinsed in PBS. For labeling with the ASIC2 and ␤-ENaC antibodies, we used a standard species conversion technique to convert rabbit anti-ASIC2 to goat by incubating samples with goat anti-rabbit monovalent Fab fragments (1:100) (10). For visualization of ASIC2 and ␤-ENaC, VSMCs were incubated with Cy5-conjugated donkey anti-mouse F(abЈ) 2 (1:100), Alexa 488-conjugated donkey anti-goat IgG (1:1,000), and Cy3-conjugated donkey anti-rabbit F(abЈ) 2 (1:100). For visualization of ASIC2 and ␥-ENaC, samples were labeled with Cy5-conjugated donkey anti-mouse F(abЈ) 2 (1:100), Cy3-conjugated donkey anti-rabbit F(abЈ)2 (1:100), and Alexa 488-conjugated donkey anti-sheep IgG (1:1,000). Staining was imaged using confocal microscopy. Experimental and control samples were examined under identical conditions, and images were prepared in Photoshop 6.0 (Adobe systems).
Cannulation of mouse middle cerebral artery for analysis of myogenic tone. After anesthetization with isoflurane, animals (6 -9 wk of age) were decapitated, and the brain was removed and placed in ice-cold physiological saline solution (PSS), pH adjusted to 7.4, with NaOH and containing (in mM) 130 NaCl, 4 KCl, 1.2 MgSO 4, 4 NaHCO3, 1.8 CaCl2, 10 HEPES, 1.18 KH2PO4, 6 glucose, and 0.03 EDTA. A middle cerebral artery (ϳ0.5-1 mm in length, 81.6 Ϯ 6.6 m inner diameter at 50 mmHg in control animals) was carefully dissected free from the surrounding tissue and placed in a vessel chamber (Living Systems, Burlington, VT) with PSS. The proximal end of the artery was placed on a tapered glass cannula and secured in place with a single silk fiber. The artery was then gently flushed to remove blood before the distal end was cannulated. The vessel was then carefully stretched longitudinally to estimate its length in vivo and pressurized to 50 mmHg and gently heated to 37°C. The vessel chamber was placed on the stage of a Nikon Elipse TE200 microscope. Bright-field images were collected with a Photometrics CoolSnap Camera (Roper Scientific, Trenton, NJ). MetaMorph software (Universal Imaging, Downingtown, PA) was used for the determination of inner and outer vessel diameters.
Depolarization-and agonist-induced constriction. Increasing concentrations of KCl (20, 40 , and 80 mM), and ␣1-receptor agonist phenylephrine (PE; 10 Ϫ7 -10 Ϫ4 M), were used to determine whether ASIC2 downregulation alters depolarization-or agonist-induced vasoconstrictor reactivity in isolated middle cerebral arteries. Diameters were determined when the vessels were pressurized to 50 mmHg. Increasing concentrations of KCl or PE were exchanged, and images were captured at peak constriction (30 -60 s for KCl and 5 min for PE). Vasoconstrictor responses were calculated as a percentage of baseline inner diameter.
Myogenic vascular reactivity. Vessels were exposed to intraluminal pressure steps (5 min, 15 mmHg each) from 15 to 90 mmHg to evaluate myogenic reactivity. Images were collected at the end of each 5-min equilibration period to determine inner diameter. After the pressure steps, vessels were allowed to equilibrate for 30 min with Ca 2ϩ -free PSS containing (in mM) 130 NaCl, 4 KCl, 1.2 MgSO4, 4 NaHCO3, 10 HEPES, 1.18 KH2PO4, 6 glucose, 0.03 EDTA, and 2 EGTA, equilibrated to pH 7.4 with NaOH, plus papaverine (10 Ϫ4 M). The same pressure steps were repeated under Ca 2ϩ -free conditions to determine the passive diameter of each vessel. At each pressure step, myogenic tone in cannulated middle cerebral arteries was calculated as the difference between the diameter with and without calcium divided by the diameter without calcium.
Calculation of wall thickness, circumferential stress, and strain. Wall tension under Ca 2ϩ -containing conditions was calculated as inner radius multiplied by the intraluminal pressure. Relative wall tension for ASIC2
ϩ/Ϫ and Ϫ/Ϫ animals was calculated compared with the wall tension in the ASIC2 ϩ/ϩ mice (100%). Wall thickness was calculated as (OD Ϫ ID)/2, where OD and ID represent outer and inner diameter (m), respectively. To determine the percent change in arterial diameter for a given change in pressure, incremental distensibility was calculated as [⌬ID/(ID ϫ ⌬P IL)] ϫ 100, where ⌬ID represents the change in inner diameter for each incremental change in intraluminal pressure (⌬P IL) during Ca 2ϩ -free conditions. For calculation of circumferential stress (CSe), intraluminal pressure was converted from millimeters of mercury to newtons per square meter, where 1 mmHg ϭ 1.334 ϫ 10 2 N/m 2 . CSe was calculated as CSe ϭ (PIL ϫ ID)/(2 wall thickness), and circumferential strain (CSa) was calculated as CSa ϭ (ID Ϫ ID15)/ID15, where ID15 represents the inner diameter at the lowest intraluminal pressure (15 mmHg) during Ca 2ϩ -free conditions. Reverse transcriptase PCR. Reverse transcriptase (RT)-PCR was used to determine the expression of transcripts associated with the 5Ј and 3Ј end of ASIC2 mRNA in the cerebral cortex of ASIC2 ϩ/ϩ , ϩ/Ϫ , and Ϫ/Ϫ mice. Oligonucleotides for the 5Ј end of the ASIC2a transcript were 5Ј-CGCCAACACCTCTACTCTCC-Ј3 and 5Ј-ATGCT-GAACTGCTTCGGTTT-Ј3. Oligonucleotides for the 3Ј end of ASIC2, which recognize the transcript sequence common to ASIC2a and ASIC2b, were 5Ј-TCCGAGAACATTCTTGTTCTGGAT-Ј3 and 5Ј-GTTCTCATCATGGCTCCCTTCCTC-Ј3. Samples were held at 94°C for 2 min, then cycled at 94°C for 30 s, 55°C for 30 s, 72°C for 30 s, for 35 cycles, and then held at 72°C for 5 min. PCR products were separated on agarose gels and visualized using ethidium bromide. PCR products were sequenced to confirm identity.
Statistics. All data are presented as means Ϯ SE. A one-way or two-way ANOVA with repeated measures was used where appropriate (SigmaStat 3.0). Differences among groups were determined using the Student-Newman-Keuls post hoc analysis. ϩ/ϩ , ϩ/Ϫ , and Ϫ/Ϫ groups, respectively).
RESULTS

Expression of ASIC2 variants in cerebral artery
VSMCs. To determine which ASIC2 splice variants are expressed in cerebral artery VSMCs, enzymatically dissociated VSMCs were immunolabeled with antibodies specific for ASIC2a and ASIC2b. Representative images of ASIC2a and ASIC2b immunolocalization are shown in Fig. 3A . The splice variant-specific antibodies, obtained from commercial sources, were directed to a region near the NH 2 terminus of ASIC2a and ASIC2b. Immunoreactivity was detected in VSMCs from WT mice and reduced or absent in ASIC2 null mice. There were several noteworthy findings. First, the localization pattern of ASIC2a at or near the surface membrane was suggested by the colocalization with ␣-actin, a near-membrane marker in freshly dissociated VSMCs, as well as the distribution in the cytoplasm. In contrast, ASIC2b staining was weaker but localized exclusively near the membrane. Second, some remaining signal for ASIC2a was present in ASIC2 Ϫ/Ϫ VSMCs compared with the no-primary antibody control. In Fig. 3B , immunolabeling with an antibody directed to the extreme COOH terminus that recognizes both ASIC2a and ASIC2b variants was used to quantitatively compare total ASIC2 expression in cerebral VSMCs from ASIC2 ϩ/ϩ , ϩ/Ϫ , and Ϫ/Ϫ mice. A concentrationdependent effect of ASIC2 gene expression is seen in VSMCs from ASIC2 mice.
Agonist-induced constriction. Vasoconstrictor responses to KCl and PE were measured to determine whether the ASIC2 genotype altered general vasoconstrictor ability. As shown in Fig. 4, A and B Pressure-induced constriction. Changes in middle cerebral artery intraluminal diameter in response to increases in intraluminal pressure in ASIC2 ϩ/ϩ , ϩ/Ϫ , and Ϫ/Ϫ littermates are shown in Fig. 5, A-C , and Ϫ/Ϫ mice, respectively). The effect of ASIC2 genotype on the development of myogenic tone is shown in Fig. 5 , D and E. The slope of the intraluminal pressure (log) versus myogenic tone relationship, an indicator of myogenic response sensitivity, is provided in Fig. 5F . The y-intercept of the intraluminal pressure (log) versus myogenic tone relationship is provided in Fig.  5G . There were two notable findings. First, when compared with the ASIC2 ϩ/ϩ group, there was a downward shift of the pressure-myogenic tone relationship in the ASIC2 Ϫ/Ϫ (Fig. 5 , D and E) group. At every pressure step, myogenic tone was significantly reduced in the ASIC2 ϩ/Ϫ group compared with the ϩ/ϩ and Ϫ/Ϫ groups. This finding is supported by data in Fig. 5, F and G, which indicate no difference in the slope but a tendency toward a reduced y-intercept of the pressure (log)-myogenic tone relationship between ASIC2 ϩ/ϩ and Ϫ/Ϫ mice. Although the y-intercept tended to be reduced in the ASIC2 Ϫ/Ϫ mice, the difference did not quite reach statistical difference (P ϭ 0.121). The second notable finding was the near absence of myogenic response in the ASIC2 ϩ/Ϫ mice (Fig. 5, D and E) ; myogenic tone did not increase with increases in intraluminal pressure, and the slope of pressure (log)-tone relationship was not different from 0, the slope of a horizontal line.
Wall tension of middle cerebral artery segments in ASIC2 mice. The development of tension under Ca 2ϩ -containing conditions is shown in Fig. 6 . Middle cerebral artery segments from ASIC2 ϩ/Ϫ mice develop significantly more absolute (Fig.  6A) and relative (Fig. 6B ) tension than ASIC2 ϩ/ϩ mice. Mechanical properties of middle cerebral artery segments in ASIC2 mice. Strain, stress, stress-strain relationship, and incremental distensibility were determined under passive (Ca 2ϩ free) conditions to determine whether mechanical properties were altered by the ASIC2 genotype. As shown in Fig. 7 , A-D, mechanical properties of the vessel wall were unchanged by the ASIC2 genotype. Additionally, the inner diameter, outer diameter, wall thickness, and wall thickness-to-lumen ratio were not different ( Table 1) .
Expression of ␤-and ␥-ENaC subunits. We used quantitative immunolabeling to determine whether ␤-or ␥-ENaC expression is altered in VSMCs of ASIC2 ϩ/ϩ , ϩ/Ϫ , and Ϫ/Ϫ mice (Fig. 8) . VSMC ␤-and ␥-ENaC levels are reduced 50 -60% in ASIC2 ϩ/Ϫ compared with ϩ/ϩ mice. However, in the homozygous null animals, ␤-and ␥-ENaC levels rebound to and above control values. Using coimmunolabeling, we determined that ASIC2 and ␤-and ␥-ENaC localize to similar regions in VSMCs dissociated from ASIC2 ϩ/ϩ cerebral vessels (Fig. 8C) . Furthermore, at least ␤-ENaC and ASIC2 colocalize in clusters on the surface of dissociated smooth muscle cells (Fig. 8D) .
Expression of a truncated ASIC2 gene product. To determine whether truncated 5Ј ASIC2 gene products were expressed in the ASIC2 model, we used RT-PCR and immunoblotting. We used RT-PCR with primers specific for 5Ј and 3Ј ends of ASIC2 mRNA to amplify ASIC2 transcripts from cerebral cortex RNA of ASIC2 ϩ/ϩ , ϩ/Ϫ , and Ϫ/Ϫ mice. We were unable to detect the transcript expression of the 3Ј end of the ASIC2 transcript in the Ϫ/Ϫ animal. However, we were able to detect the expression of the 5Ј end of ASIC2a splice variant in the Ϫ/Ϫ animal, suggesting that ASIC2 transcripts encoding the 5Ј region are expressed in the ASIC2 Ϫ/Ϫ mouse cerebral cortex (Fig. 9A) . We then used immunoblotting to determine whether a truncated ASIC2 protein was expressed. We detected a fast-migrating protein (ϳ12 kDa) in the cerebral cortex Triton X-100-soluble lysates from ASIC2 ϩ/Ϫ and Ϫ/Ϫ mice, using an antibody directed to the NH 2 terminus of ASIC2a
Wall Tension (% Control) Fig. 6 . Wall tension development in middle cerebral arteries of ASIC2 ϩ/ϩ , ϩ/Ϫ , and Ϫ/Ϫ mice. Wall tension was determined under Ca 2ϩ -containing conditions. A: absolute wall tension in middle cerebral arteries increased with intraluminal pressure for all groups. However, wall tension increased significantly more in the ASIC2 ϩ/Ϫ group compared with the ASIC2 ϩ/ϩ group. B: changes in wall tension relative to the control ASIC2 ϩ/ϩ group. When compared with those of the ASIC2 ϩ/ϩ group, middle cerebral arteries from ASIC2 ϩ/Ϫ group developed significantly more wall tension at 60, 75, and 90 mmHg. *P Ͻ 0.05, significantly different. (Fig. 9B) . The product was not detected in the cerebral cortex lysates from ASIC2 ϩ/ϩ mice. Consistent with the increased expression of a NH 2 -terminal ASIC2a protein, the immunolabeling signal (with the same antibody) nearly doubled in the cerebral VSMCs in ASIC2 Ϫ/Ϫ mice.
DISCUSSION
The myogenic response is a mechano-dependent response inherent to VSMCs and thought to be initiated by the activation of mechanosensitive ion channels in the vascular smooth muscle. Although the mechanisms underlying VSMC constriction are well established, the sensor of the mechanical stimulus is still unknown (11, 12) . Members of the DEG/ENaC/ASIC protein family have been identified as evolutionarily conserved ion channels involved in mechanosensation (17, 28) . Previous studies from our laboratory have demonstrated the importance of the ENaC proteins in the pressure-induced vasoconstriction of cerebral arteries; however, the role of the closely related ASIC proteins has not been determined (8) . The aim of these studies was to determine whether ASIC2 is important in maintaining cerebral vasoconstriction of the middle cerebral artery. The major findings of this study are that 1) ASIC2a and ASIC2b are present in dissociated VSMCs and 2) ASIC2 is required for normal pressure-induced constrictor responses.
ASIC2 expression in VSMCs. Two ASIC2 splice variants have been identified: ASIC2a and ASIC2b. The splice variants vary in their NH 2 -terminal sequence but share a common extracellular domain and COOH-terminal regions (25) . ASIC2a and ASIC2b are often found colocalized in similar tissues, such as the brain, sour taste receptors, and dorsal root ganglion (3, 18, 29) . Although we detected more ASIC2a immunolabeling signal, we are unable to determine whether this is due to higher expression levels or better antibody specificity of the ASIC2a antibody. ASIC2a can form an ion-conducting pore. Although ASIC2b does not conduct ions by itself, it modulates the activity of other ASIC channels (17, 18, 29) . Thus it is likely that ASIC2a and ASIC2b may play similar roles in VSMCs.
The magnitude of the myogenic constrictor responses in the middle cerebral artery of WT mice (16% tone at 90 mmHg) is consistent with that of other recent publications (2, 4). In our current investigation, we found peak myogenic tone (90 mmHg) in the ASIC2 Ϫ/Ϫ mice was inhibited by ϳ40%. Other investigations have shown that mechanical activation of certain touch and viseceral mechanoreceptor fibers was inhibited 20 -50% in ASIC2 Ϫ/Ϫ mice (22, 23) . Thus the magnitude of the phenotypic difference between ASIC2 ϩ/ϩ and Ϫ/Ϫ is comparable. ASIC2 Ϫ/Ϫ mice appear normal, and preliminary reports suggest blood pressure is not different from ASIC2 ϩ/ϩ ; the phenotype of the ASIC2 ϩ/Ϫ has never been reported, so we are unable to determine whether the exaggerated phenotype in the ASIC2 ϩ/Ϫ is specific to pressure-induced constriction in VSMCs (23, 27) .
ASIC2 genotype on myogenic tone. When compared with those from ASIC2 ϩ/ϩ mice, middle cerebral arteries from ASIC2 Ϫ/Ϫ mice had less tone at each intraluminal pressure step; however, the vessels still constricted to increases in intraluminal pressure. This finding suggests that although the baseline tone in the middle cerebral arteries was reduced, Data are means Ϯ SE. ASIC2, acid-sensing ion channel 2; ϩ/ϩ, wild-type; ϩ/Ϫ, heterozygous; Ϫ/Ϫ, null. the sensitivity of the myogenic response was not changed in the ASIC2 Ϫ/Ϫ mice. To quantify this difference, we used linear regression of the pressure (log)-myogenic tone relationship and obtained the mean slope and y-intercept for ASIC2 ϩ/ϩ , ϩ/Ϫ , and Ϫ/Ϫ mice. The slope and the y-intercept were used assess the sensitivity and basal level of tone, respectively. The slope of the pressure (log) versus myogenic tone curve was not different in ASIC2 ϩ/ϩ versus Ϫ/Ϫ mice; however, the intercept tended to be lower in the ASIC2 Ϫ/Ϫ mice. These data confirm our conclusion that the sensitivity of the myogenic response was not altered, but the basal tone was lower in middle cerebral arteries from ASIC2 Ϫ/Ϫ mice. These findings suggest that although ASIC2 is involved in the myogenic response, ASIC2 by itself may not be a critical requirement in determining the ability of the middle cerebral artery to constrict in response to an increase in pressure; however, it is critical to setting baseline pressure-dependent tone.
Why is pressure-induced constriction abolished in middle cerebral arteries of ASIC2
ϩ/Ϫ mice? Our finding that the myogenic response was abolished in cerebral vessels in 
ASIC2
ϩ/Ϫ mice was unexpected. We speculated that the expression of ␤-and/or ␥-ENaC might be altered since previous investigations from our laboratory indicated that ␤-and ␥-ENaC were required for pressure-induced constriction in renal vessels and that those of other laboratories indicate ASIC2 biochemically interacts with ␤-and ␥-ENaC (15, 19) . It is possible that the downregulation of ␤-and ␥-ENaC in the ASIC2 ϩ/Ϫ mice may contribute to the loss of pressure-induced constriction. Similarly, the upregulation of ␥-ENaC in the ASIC2 Ϫ/Ϫ may help restore myogenic responsiveness and mask the importance of ASIC2. This compensatory upregulation of other DEG/ENaC proteins in the knockout might explain the lack of effect of the phenotypic difference in ASIC2
Ϫ/Ϫ mice in certain studies (6, 26) . Taken together, these findings suggest that ␤-ENaC, ␥-ENaC, and ASIC2 interact directly or indirectly to form a heteromeric channel.
Why are ␤-and ␥-ENaC downregulated in VSMCs from ASIC2
ϩ/Ϫ mice? The mechanism mediating the downregulation of ␤-and ␥-ENaC is unknown; however, we considered the possibility that short, truncated NH 2 -terminal fragments of ASIC2 might suppress ␤-and ␥-ENaC for several reasons. First, in preliminary studies for the current investigation, we observed considerable immunostaining for three different ASIC2a antibodies directed to the NH 2 terminus/extracellular domain in the ASIC2 Ϫ/Ϫ VSMCs. Second, the ASIC2 targeting vector contained a neomycin cassette near the 3Ј end of the ASIC2 gene in the coding region of the second membranespanning domain (23) , leaving the possibility that mRNA from NH2-terminal ASIC2a expression, normalized for ␣-actin, was increased more than twofold in VSMCs from ASIC2 Ϫ/Ϫ mice (n ϭ 43-85 VSMCs/group). *P Ͻ 0.01, significantly different from ASIC2 ϩ/ϩ and ϩ/Ϫ groups. NEO, neomycin resistance cassette.
the 5Ј end could still be transcribed. Third, NH 2 -terminal truncations of DEG/ENaC proteins are known to suppress the expression of other interacting proteins (1, 13) . Finally, ASIC2 biochemically interacts with ENaC proteins (5, 19) . These four lines of evidence compelled us to determine whether truncated ASIC2 molecules are expressed in the ASIC2 mice. We detected a truncated ASIC2 transcript and protein (ϳ12 kDa) using RT-PCR and Western blot analysis in the cerebral cortex from ASIC2 ϩ/Ϫ and Ϫ/Ϫ but not ϩ/ϩ mice. Although these findings suggest the expression of a truncated ASIC2 molecule in the ϩ/Ϫ and Ϫ/Ϫ mice, it is unknown whether this is responsible for the downregulation of ␤-and ␥-ENaC in the ASIC2 ϩ/Ϫ VSMCs.
What is the importance of ASIC2 in the myogenic response?
Because of the down-and upregulation of ␤-/␥-ENaC in the ASIC2 ϩ/Ϫ and Ϫ/Ϫ mice, it is difficult to separate the importance of ASIC2 from ␤-/␥-ENaC in pressure-induced constriction in the ASIC2 knockout model. In previous investigations, we have been able to use pharmacological and gene-silencing approaches [i.e., small-interfering RNA (siRNA)] to determine the importance of ␤-/␥-ENaC proteins in pressure-induced constriction. Unfortunately, specific ASIC2 antagonists are not available, and the small magnitude of the myogenic response in mouse cerebral vessels coupled with the loss of responsiveness that occurs following the siRNA incubation period renders gene-silencing approaches prohibitive. Even though the sensitivity of the pressure-myogenic tone curve in the ASIC2 Ϫ/Ϫ was unchanged, the curve was shifted downward (despite the increased expression of ␥-ENaC), which suggests that ASIC2 participates in establishing basal levels of myogenic tone.
Although we do not understand the precise mechanisms leading to the loss of pressure-induced constriction in the middle cerebral arteries of ASIC2 ϩ/Ϫ mice, the ASIC2 ϩ/Ϫ mouse may be an excellent model to investigate the physiological importance of pressure-induced constriction. For example, this model can potentially be used to determine the importance of myogenic constriction in cerebral blood flow autoregulation or protection of the fragile cerebral microvasculature from pressure-related injury such as hypertensioninduced edema or hemorrhagic stroke. How do ASIC2 proteins participate in pressure-induced constriction? Previous findings from our laboratory have suggested that ␤-and ␥-ENaC are components of a mechanosensitive ion channel complex in VSMCs. The mechanosensor complex in VSMCs is probably similar to the mechanosensor formed by Caenorhabditis elegans DEG proteins (28) . In this model, the mechanosensor consists of an ion channel pore anchored to the extracellular matrix, and cytoskeleton, either directly or via linking proteins. Mechanical force applied to the extracellular matrix modulates channel activity. We speculate that members of the ENaC/ASIC family form the ion channel pore, including ASIC2, ␤-, and ␥-ENaC. Several lines of evidence suggest the potential for interaction between ASIC2 and other ENaC proteins. First, ␤-and ␥-ENaC are expressed in similar VSMC populations. Second, in our current investigation, ␤-and ␥-ENaC expression levels are altered in ASIC2 mice. Third, other investigators have shown ASIC2 interacts with ␤-and ␥-ENaC (5, 19) . Finally, the recent identification of the crystal structure of ASIC1 indicates a trimeric structure that may apply to other members of the DEG family (14) . Thus we speculate ASIC2 may interact with ␤-and ␥-ENaC to form the ion-conducting unit of a mechanosensor complex.
In summary, our data demonstrate that ASIC2a and ASIC2b proteins are expressed in middle cerebral artery VSMCs. The disruption of normal ASIC2 expression does not alter agonistor depolarization-induced vasoconstriction. However, the disruption of ASIC2 expression alters expression of vascular smooth muscle ENaC proteins and pressure-induced vascular tone. These findings suggest that ASIC2 may interact with ␤-and ␥-ENaC to form the ion-conducting unit of a mechanosensor that transduces pressure-induced vascular stretch into vasoconstriction and thereby play an important role in the local regulation of cerebral blood flow. The ASIC2 model may serve as a useful tool to advance our understanding of the importance of myogenic constriction in hyperperfusion/hypertensionrelated injury.
